Atheroma and coronary bifurcations: before and after stenting.
暂无分享,去创建一个
Masataka Nakano | Renu Virmani | R. Virmani | F. Otsuka | S. Yazdani | M. Nakano | F. Kolodgie | Saami K Yazdani | Fumiyuki Otsuka | Frank D Kolodgie
[1] Neville Kukreja,et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study , 2007, The Lancet.
[2] E. Edelman,et al. Dynamic flow alterations dictate leukocyte adhesion and response to endovascular interventions. , 2004, The Journal of clinical investigation.
[3] Michael Joner,et al. Vascular Responses to Drug Eluting Stents: Importance of Delayed Healing , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[4] M. Bell,et al. Immediate and long-term outcome of intracoronary stent implantation for true bifurcation lesions. , 2000, Journal of the American College of Cardiology.
[5] S. de Servi,et al. Real-world outcome of coronary bifurcation lesions in the drug-eluting stent era: results from the 4,314-patient Italian Society of Invasive Cardiology (SICI-GISE) Italian Multicenter Registry on Bifurcations (I-BIGIS). , 2010, American heart journal.
[6] Seung‐Jung Park,et al. Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation. , 2005, Journal of the American College of Cardiology.
[7] Gregg W Stone,et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. , 2004, The New England journal of medicine.
[8] A. Farb,et al. Stent thrombosis redux--the FDA perspective. , 2007, The New England journal of medicine.
[9] F. Grosveld,et al. Atherosclerotic Lesion Size and Vulnerability Are Determined by Patterns of Fluid Shear Stress , 2006, Circulation.
[10] Renu Virmani,et al. Pathological findings at bifurcation lesions: the impact of flow distribution on atherosclerosis and arterial healing after stent implantation. , 2010, Journal of the American College of Cardiology.
[11] David G Rizik,et al. Bifurcation coronary artery disease: current techniques and future directions (part 1). , 2008, The Journal of invasive cardiology.
[12] D. Ku,et al. Pulsatile Flow and Atherosclerosis in the Human Carotid Bifurcation: Positive Correlation between Plaque Location and Low and Oscillating Shear Stress , 1985, Arteriosclerosis.
[13] D. Ku,et al. Pulsatile flow in the human left coronary artery bifurcation: average conditions. , 1996, Journal of biomechanical engineering.
[14] A. Svindland,et al. Localization of atherosclerotic lesions in the bifurcation of the main left coronary artery. , 1983, Atherosclerosis.
[15] Nine-month outcome of patients treated by percutaneous coronary interventions for bifurcation lesions in the recent era: a report from the Prevention of Restenosis with Tranilast and its Outcomes (PRESTO) trial. , 2005, Journal of the American College of Cardiology.
[16] Antonio Colombo,et al. Bifurcation disease: what do we know, what should we do? , 2008, JACC. Cardiovascular interventions.
[17] M. H. Friedman,et al. Influence of curvature dynamics on pulsatile coronary artery flow in a realistic bifurcation model. , 2004, Journal of biomechanics.
[18] Antonio Colombo,et al. Randomized Study to Evaluate Sirolimus-Eluting Stents Implanted at Coronary Bifurcation Lesions , 2004, Circulation.
[19] A. Tzafriri,et al. Strut Position, Blood Flow, and Drug Deposition: Implications for Single and Overlapping Drug-Eluting Stents , 2005, Circulation.
[20] Rob Krams,et al. Shear stress affects the intracellular distribution of eNOS: direct demonstration by a novel in vivo technique. , 2005, Blood.
[21] Imad Sheiban,et al. Update on dedicated bifurcation stents. , 2009, Journal of interventional cardiology.
[22] B. Berk,et al. Laminar shear stress: mechanisms by which endothelial cells transduce an atheroprotective force. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[23] G. Hutchins,et al. Correlation between wall shear and intimal thickness at a coronary artery branch. , 1987, Atherosclerosis.
[24] Jeffrey W Moses,et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. , 2003, The New England journal of medicine.
[25] Michael M. Resch,et al. Pulsatile non-Newtonian blood flow in three-dimensional carotid bifurcation models: a numerical study of flow phenomena under different bifurcation angles. , 1991, Journal of biomedical engineering.
[26] Young-Seok Cho,et al. Physiological evaluation of the provisional side-branch intervention strategy for bifurcation lesions using fractional flow reserve. , 2008, European heart journal.
[27] Michael Joner,et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. , 2006, Journal of the American College of Cardiology.
[28] Johan Lindbäck,et al. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. , 2007, The New England journal of medicine.
[29] I. Iakovou,et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. , 2005, JAMA.
[30] Simon Wandel,et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis , 2007, The Lancet.
[31] Samin K. Sharma,et al. Coronary bifurcation lesions: a current update. , 2010, Cardiology clinics.
[32] I. Seong,et al. Sirolimus-Eluting Stent Versus Paclitaxel-Eluting Stent for Patients With Long Coronary Artery Disease , 2006, Circulation.
[33] B. Fox,et al. Distribution of fatty and fibrous plaques in young human coronary arteries. , 1982, Atherosclerosis.